dipyridamole has been researched along with Orphan Diseases in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Orphan Diseases: Rare diseases that have not been well studied.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The strict adherence to aspirin and dipyridamole has led to no stroke or progression of the vasculopathy for 8 years." | 3.73 | Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia. ( Hara, T; Kira, R; Ohga, S; Sanefuji, M; Torisu, H; Yoshiura, T, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanefuji, M | 1 |
| Ohga, S | 1 |
| Kira, R | 1 |
| Yoshiura, T | 1 |
| Torisu, H | 1 |
| Hara, T | 1 |
1 other study available for dipyridamole and Orphan Diseases
| Article | Year |
|---|---|
Moyamoya syndrome in a splenectomized patient with beta-thalassemia intermedia.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; beta-Thalassemia; Carotid Arteries; Di | 2006 |